Real-Time PCR Detects Malaria in Children
By LabMedica International staff writers Posted on 28 Jun 2012 |
Quantitative real-time polymerase chain reaction PCR (qPCR) on blood samples is more sensitive than thick film microscopy for malaria diagnosis.
The molecular method can be used to determine the parasitemia of African children infected with Plasmodium falciparum in both plasma and whole blood samples and has been compared with microscopic techniques.
Scientists at the University of Oxford (Headington, UK) working with an international team conducted a double-blind randomized placebo-controlled trial in Southern Mozambique from September 2005 to March 2009. Study participants were followed up until age 24 months. Blood slides were read to quantify parasitemia. Plasma samples were stored at -80 °C for three to four years before extraction of DNA. Dried bloodspots collected onto filter paper were stored for the same period at 4 °C with silica gel.
A total of 548 samples were analyzed by qPCR on DNA extracted from whole blood on filter paper (qPCR-blood) and plasma (qPCR-plasma). Of these, 143 (26%) were found to be P. falciparum positive by qPCR-blood, while the qPCR-plasma method detected 37 (7%) as positive. Agreement between both techniques was 78.1%. Parasite infection detected by microscopy showed greater agreement with detection by qPCR-plasma (96.85%) than did qPCR-blood (69.7%). However, qPCR-blood detected parasitemia in approximately 3.5 fold more samples than qPCR-plasma or thick film microscopy.
The authors concluded that qPCR using parasite DNA from whole blood is more sensitive to detect submicroscopic levels of parasitemia than using parasite DNA from plasma. However, the data demonstrated that the performance of qPCR on plasma samples is similar to the performance of microscopy, suggesting that qPCR on plasma can be used as a substitute to microscopy when performing retrospective studies with limited material and when blood smears are unavailable. This approach, together with developments in the use of loop-mediated isothermal amplification may assist in making molecular detection of malaria infection in the field more common. The study was published on June 15, 2012, in the Malaria Journal.
Related Links:
University of Oxford
The molecular method can be used to determine the parasitemia of African children infected with Plasmodium falciparum in both plasma and whole blood samples and has been compared with microscopic techniques.
Scientists at the University of Oxford (Headington, UK) working with an international team conducted a double-blind randomized placebo-controlled trial in Southern Mozambique from September 2005 to March 2009. Study participants were followed up until age 24 months. Blood slides were read to quantify parasitemia. Plasma samples were stored at -80 °C for three to four years before extraction of DNA. Dried bloodspots collected onto filter paper were stored for the same period at 4 °C with silica gel.
A total of 548 samples were analyzed by qPCR on DNA extracted from whole blood on filter paper (qPCR-blood) and plasma (qPCR-plasma). Of these, 143 (26%) were found to be P. falciparum positive by qPCR-blood, while the qPCR-plasma method detected 37 (7%) as positive. Agreement between both techniques was 78.1%. Parasite infection detected by microscopy showed greater agreement with detection by qPCR-plasma (96.85%) than did qPCR-blood (69.7%). However, qPCR-blood detected parasitemia in approximately 3.5 fold more samples than qPCR-plasma or thick film microscopy.
The authors concluded that qPCR using parasite DNA from whole blood is more sensitive to detect submicroscopic levels of parasitemia than using parasite DNA from plasma. However, the data demonstrated that the performance of qPCR on plasma samples is similar to the performance of microscopy, suggesting that qPCR on plasma can be used as a substitute to microscopy when performing retrospective studies with limited material and when blood smears are unavailable. This approach, together with developments in the use of loop-mediated isothermal amplification may assist in making molecular detection of malaria infection in the field more common. The study was published on June 15, 2012, in the Malaria Journal.
Related Links:
University of Oxford
Latest Microbiology News
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
- Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions
Channels
Clinical Chemistry
view channel
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read morePathology
view channel
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more
New Error-Corrected Method to Help Detect Cancer from Blood Samples Alone
"Liquid biopsy" technology, which relies on blood tests for early cancer detection and monitoring cancer burden in patients, has the potential to transform cancer care. However, detecting the mutational... Read more
"Metal Detector" Algorithm Hunts Down Vulnerable Tumors
Scientists have developed an algorithm capable of functioning as a "metal detector" to identify vulnerable tumors, marking a significant advancement in personalized cancer treatment. This breakthrough... Read more
Novel Technique Uses ‘Sugar’ Signatures to Identify and Classify Pancreatic Cancer Cell Subtypes
Pancreatic cancer is often asymptomatic in its early stages, making it difficult to detect until it has progressed. Consequently, only 15% of pancreatic cancers are diagnosed early enough to allow for... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more